Accession Number:



Womens Ischemia Trial to Reduce Events in Non-Obstructive CAD (WARRIOR)

Descriptive Note:

[Technical Report, Annual Report]

Corporate Author:

University of Florida

Personal Author(s):

Report Date:


Pagination or Media Count:



The WARRIOR trial is a multicenter, prospective, randomized, blinded outcome evaluation PROBE design evaluating intensive medical therapy vs usual care in 4,422 symptomatic women with ischemia but no obstructive CAD. The study aims are to determine whether an intensive medication treatment strategy to modify risk factors in women with chest pain andor abnormal stress tests, but non-obstructed coronary arteries will reduce their likelihood of dying, having a heart attack, stroke or being hospitalized. This project will activate 50-125 recruitment sites from across the US to enroll and follow these women for up to three years to assess adverse outcomes.

Subject Categories:

  • Anatomy and Physiology
  • Medicine and Medical Research

Distribution Statement:

[A, Approved For Public Release]